Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$9.76
0.161.67%
At close: May 19, 5:00 PM EST
$9.76
N/A
After Hours: 4:00 PM EST
Fennec Pharmaceuticals Inc Analyst Ratings
FENCNASDAQ
Earnings: Q1 2026 Earnings were released on Thu May 14th, before the market open
Conference Call: The most recent conference call started at 8:30 AM, 5 days agoClick to view the webcast
Fennec Pharmaceuticals Analyst Ratings and Price Targets | NASDAQ:FENC | Benzinga
Fennec Pharmaceuticals Inc has a consensus price target of $14.5 based on the ratings of 4 analysts. The high is $18 issued by Piper Sandler on January 9, 2026. The low is $13 issued by Wedbush on April 16, 2026. The 3 most-recent analyst ratings were released by Wedbush, Piper Sandler, and HC Wainwright & Co. on April 16, 2026, January 9, 2026, and August 21, 2025, respectively. With an average price target of $14.67 between Wedbush, Piper Sandler, and HC Wainwright & Co., there's an implied 50.27% upside for Fennec Pharmaceuticals Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Wedbush
Piper Sandler
HC Wainwright & Co.
Craig-Hallum
1calculated from analyst ratings
Analyst Ratings for Fennec Pharmaceuticals
Loading calendar...
FAQ
What is the target price for Fennec Pharmaceuticals (FENC) stock?
The latest price target for Fennec Pharmaceuticals (NASDAQ:FENC) was reported by Wedbush on April 16, 2026. The analyst firm set a price target for $13.00 expecting FENC to rise to within 12 months (a possible 33.20% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Fennec Pharmaceuticals (FENC)?
The latest analyst rating for Fennec Pharmaceuticals (NASDAQ:FENC) was provided by Wedbush, and Fennec Pharmaceuticals reiterated their outperform rating.
When was the last upgrade for Fennec Pharmaceuticals (FENC)?
There is no last upgrade for Fennec Pharmaceuticals
When was the last downgrade for Fennec Pharmaceuticals (FENC)?
There is no last downgrade for Fennec Pharmaceuticals.
When is the next analyst rating going to be posted or updated for Fennec Pharmaceuticals (FENC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Fennec Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Fennec Pharmaceuticals was filed on April 16, 2026 so you should expect the next rating to be made available sometime around April 16, 2027.
Is the Analyst Rating Fennec Pharmaceuticals (FENC) correct?
While ratings are subjective and will change, the latest Fennec Pharmaceuticals (FENC) rating was a reiterated with a price target of $13.00 to $13.00. The current price Fennec Pharmaceuticals (FENC) is trading at is $9.76, which is out of the analyst’s predicted range.
